New guidelines about tetanus vaccination schedules in Europe should be evaluated with caution; Comment on: Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers. By Borrella-Venturini et al.

摘要: To the Editor: The recent paper by Borella-Venturini et al.[1] gives us an opportunity to discuss the guidelines about tetanus vaccination in France and Europe. In France, the vaccination schedule was updated in 2013 to a 20-year-interval between booster shots of tetanus vaccine in adults [2]. However, the risk–benefit balance of these new guidelines needs to be carefully evaluated, following a case of tetanus in a ‘vaccinated-as-recommended-patient’. A 50-year-old man came to the emergency unit of Brignoles, France, for abnormal movements. His left heel had been wounded by a rusty nail while walking in a field 15 days before. His last vaccination for tetanus was in 1999 at the age of 33, 17 years previously. The wound was cleaned 24 h later but became inflamed. Eight days after the injury, he felt cramps in the left leg. He then developed bilateral dyskinesia of upper and lower limbs and went to the emergency …